1. Home
  2. VLY vs PTGX Comparison

VLY vs PTGX Comparison

Compare VLY & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Valley National Bancorp

VLY

Valley National Bancorp

HOLD

Current Price

$14.73

Market Cap

7.6B

Sector

Finance

ML Signal

HOLD

Logo Protagonist Therapeutics Inc.

PTGX

Protagonist Therapeutics Inc.

HOLD

Current Price

$128.75

Market Cap

6.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VLY
PTGX
Founded
1927
2006
Country
United States
United States
Employees
3675
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.6B
6.4B
IPO Year
N/A
2016

Fundamental Metrics

Financial Performance
Metric
VLY
PTGX
Price
$14.73
$128.75
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
13
13
Target Price
$14.65
$108.23
AVG Volume (30 Days)
6.9M
727.2K
Earning Date
04-23-2026
05-07-2026
Dividend Yield
3.31%
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.05
Revenue
N/A
N/A
Revenue This Year
$23.58
$874.25
Revenue Next Year
$8.51
N/A
P/E Ratio
$13.14
$2,632.40
Revenue Growth
N/A
N/A
52 Week Low
$8.96
$50.49
52 Week High
$14.94
$131.87

Technical Indicators

Market Signals
Indicator
VLY
PTGX
Relative Strength Index (RSI) 61.76 74.08
Support Level $13.30 $94.48
Resistance Level $14.83 N/A
Average True Range (ATR) 0.34 4.88
MACD 0.00 1.37
Stochastic Oscillator 82.28 86.62

Price Performance

Historical Comparison
VLY
PTGX

About VLY Valley National Bancorp

Valley National Bancorp is a bank holding company that offers a full suite of national and regional banking solutions through various commercial, private banking, retail, insurance, and wealth management financial services products. It provides personalized service and customized solutions to assist its customers with their financial service needs. The group also offers niche financial services, including loan and deposit products for homeowners associations, cannabis-related business banking, and venture banking, which offers nationally. It manages its business operations under operating segments consisting of Consumer Banking; Commercial Banking; and Treasury and Corporate Other. The group generates the majority of its revenue from the Commercial Banking Segment.

About PTGX Protagonist Therapeutics Inc.

Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology, hematology, and metabolic diseases. Its pipeline includes clinical-stage and preclinical candidates such as rusfertide for polycythemia vera, icotrokinra for inflammatory diseases, and other programs targeting IL-17, obesity, and iron metabolism disorders, developed through internal research and strategic collaborations.

Share on Social Networks: